Ovarian cancer experts and patients from Cambridge and Birmingham have developed clear, accessible information in multiple languages about the benefits of genetic testing for ovarian cancer patients.
A cancer drug currently in the final stages of clinical trials could offer hope for the treatment of a wide range of inflammatory diseases, including gout, heart failure, cardiomyopathy, and atrial fibrillation, say Cambridge scientists.
We are immensely grateful to Ely City Golf Club Ladies’ teams for raising £8,500 to support our research in ovarian cancer at the Cancer Research UK Cambridge Centre.
Seven (including two in the Black Leaders in Cancer initiative) four-year MRes + PhD studentships and five Clinical Research Training Fellowships are available, starting in October 2024.
In recognition of Gynaecological Cancer Awareness Month, Prof James Brenton looks at the reasons for optimism around the disease and Barbara and Lorraine share special moments they have been able to enjoy thanks to research.
To mark Gynaecological Cancer Awareness Month we are immensely grateful to Shirley, Melanie and Margaret from our ovarian cancer patient group for sharing the special moments they have enjoyed thanks to research.
Children with neuroblastoma – responsible for 15% of cancer deaths in this age group – could in future be given treatments with fewer side-effects than those associated with the current chemotherapy, thanks to a discovery by researchers at the University